CCWM
TMO icon

Cassaday & Co Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Cassaday & Co Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Sell
2,697
-15
-0.6% -$7.2K 0.03% 127
2026
Q1 		$1.33M Sell
2,712
-210
-7% -$114K 0.03% 112
2025
Q4 		$1.69M Sell
2,922
-759
-21% -$429K 0.04% 100
2025
Q3 		$1.79M Sell
3,681
-5
-0.1% -$2.33K 0.04% 95
2025
Q2 		$1.49M Sell
3,686
-77
-2% -$32.2K 0.04% 100
2025
Q1 		$1.87M Buy
3,763
+1,477
+65% +$800K 0.05% 80
2024
Q4 		$1.19M Buy
2,286
+20
+0.9% +$11K 0.03% 101
2024
Q3 		$1.4M Buy
2,266
+88
+4% +$52.1K 0.04% 86
2024
Q2 		$1.2M Sell
2,178
-32
-1% -$18.3K 0.04% 89
2024
Q1 		$1.28M Sell
2,210
-65
-3% -$36.5K 0.04% 87
2023
Q4 		$1.21M Buy
2,275
+285
+14% +$138K 0.04% 91
2023
Q3 		$1.01M Sell
1,990
-124
-6% -$66.1K 0.04% 86
2023
Q2 		$1.1M Buy
2,114
+48
+2% +$25.9K 0.04% 84
2023
Q1 		$1.19M Sell
2,066
-69
-3% -$38.9K 0.05% 77
2022
Q4 		$1.18M Buy
+2,135
New +$1.13M 0.05% 79

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Cassaday & Co Wealth Management's TMO Position: Q2 2026 in Review

Cassaday & Co Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 0.55% in Q2 2026, selling an estimated $7.2K and leaving 2,697 shares worth $1.35M. The position accounts for 0.03% of the portfolio, ranked #127.

Cassaday & Co Wealth Management first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.87M in Q1 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Cassaday & Co Wealth Management held 2,697 shares of Thermo Fisher Scientific worth $1.35M as of Q2 2026.
  • Cassaday & Co Wealth Management sold 15 Thermo Fisher Scientific shares in Q2 2026, an estimated $7.2K.
  • Thermo Fisher Scientific made up 0.03% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #127 holding.
  • Cassaday & Co Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
  • Cassaday & Co Wealth Management's Thermo Fisher Scientific position peaked at $1.87M in Q1 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.